Addus HomeCare (ADUS)

• Market cap: $1.8B
• 1 day: 0.84%
• 5 days: -0.20%
• 1 month: 8.66%
• 3 months: -22.22%
• 6 months: -23.60%
• Year to date: -20.44%
• 1 year: 4.33%
• 5 years: 26.87%
• 10 years: 247.49%
• Sector: Healthcare
• Industry: Medical Care Facilities

About: Addus HomeCare Corp is engaged in the provision of in-home personal care services. It operates through the segments such as Personal care segment, which is a key revenue driver, provides non-medical assistance with activities of daily living, primarily to persons who are at risk of hospitalization or institutionalization, such as the elderly, chronically ill and disabled. The Hospice segment provides physical, emotional and spiritual care for people who are terminally ill and their families. Its Home health segment provides services that are primarily medical in nature to those individuals who may require assistance during an illness or after surgery.

Employees: 49,703

Fund manager confidence

Based on 2024 Q4 regulatory disclosures by fund managers ($100M+ AUM)

177% more call options, than puts

Call options by funds: $1.49M | Put options by funds: $539K

49% more repeat investments, than reductions

Existing positions increased: 130 | Existing positions reduced: 87

2.7% more ownership

Funds ownership: 97.2% [Q3] → 99.9% (+2.7%) [Q4]

3% less capital invested

Capital invested by funds: $2.34B [Q3] → $2.27B (-$71.7M) [Q4]

5% less first-time investments, than exits

New positions opened: 36 | Existing positions closed: 38

1% less funds holding

Funds holding: 306 [Q3] → 302 (-4) [Q4]

50% less funds holding in top 10

Funds holding in top 10: 2 [Q3] → 1 (-1) [Q4]

Research analyst outlook

6 Wall Street Analysts provided 1 year price targets over the past 3 months

• Low target: $129 30% upside
• Avg. target: $144 45% upside
• High target: $150 52% upside

6 analyst ratings

• positive: 6 100%
• neutral: 0 0%
• negative: 0 0%

JMP Securities Nicholas Jones 28% 1-year accuracy 23 / 82 met price target	52% upside $150	Market Outperform Reiterated	22 Apr 2025
JMP Securities Constantine Davides 27% 1-year accuracy 9 / 33 met price target	52% upside $150	Market Outperform Maintained	10 Apr 2025
Stephens & Co. Scott Fidel 46% 1-year accuracy 19 / 41 met price target	44% upside $142	Overweight Reiterated	12 Mar 2025
Macquarie Tao Qiu 30% 1-year accuracy 6 / 20 met price target	30% upside $129	Outperform Maintained	27 Feb 2025
Stephens & Co. Raj Kumar 57% 1-year accuracy 4 / 7 met price target	44% upside $142	Overweight Maintained	26 Feb 2025